Lunge und Autoimmunerkrankungen - Klinik und Diagnostik

Zusammenfassung

Die Lunge ist bei vielen Autoimmunerkrankungen betroffen. Der vorliegende Übersichtsartikel stellt die pulmonalen Manifestationsformen der Vaskulitiden, rheumatischer Erkrankungen und Kollagenosen dar. Das klinische Bild und das diagnostische Vorgehen werden beschrieben.

Summary

Pulmonary involvement is commonly seen in autoimmune disease. In this review the clinical presentation of pulmonary involvement in vasculitis, rheumatoid arthritis and connective tissue disease is presented. Clinical symptoms and diagnostic approach will be discussed.

Schlüsselwörter

Alveolitis - Diffuse alveoläre Hämorrhagie - Fibrose - Kollagenose - Pulmonale Hypertonie - Vaskulitis

Key words

alveolitis - connective tissue disease - diffuse alveolar haemorrhage - fibrosis - pulmonary hypertension - vasculitis

Literatur

• 1 Cheema G S, Quismorio F P. Interstitial lung disease in systemic lupus erythematodes.  Curr Opin Pulm Med. 2000;  6 424-429
• 2 Cordier J F, Valeyre D, Guillevin L. et al . Pulmonary WegenerŽs granulomatosis: a clinical and imaging study of 77 cases.  Chest. 1990;  97 906-912
• 3 El Maqhraoui A, Chaouir S, Abid A. et al . Lung findings on thoracic high-resolution computed tomography in patients with ankylosing spondylitis. Correlations with disease duration, clinical findings and pulmonary function testing.  Clin Rheumatol. 2004;  23 123-128
• 4 Fagan K A, Badesch D B. Pulmonary hypertension associated with connective tissue disease.  Prog Cardiovasc Dis. 2002;  45 225-234
• 5 Frank S I, Weg J G, Harkleroas L E, Fitch R F. Pulmonary dysfunction in rheumatoid arthritis.  Chest. 1973;  63 27-34
• 6 Guillevin L, Durand-Gasselin R, Cevallos M. et al . Microscopi polyangiits. Clinical and laboratory findings in eighty-five patients.  Arthritis Rheum. 1999;  42 421-430
• 7 Gross W L, Schmitt W H, Csernok E. ANCA and associated diseases. Immunodiagnostic and pathogenetic aspects.  Clin Exp Immunol. 1992;  91 1-2
• 8 Hill C L, Zhang Y, Sigurgeirsson B. et al . Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study.  Lancet. 2001;  357 96-100
• 9 Hoffmann G S, Kerr G S, Leavitt R Y. et al . Wegener granulomatosis: an analysis of 158 patients.  Ann Intern Med. 1992;  116 488-498
• 10 Jayne D R, Gaskin C, Pusey C D. et al . ANCA and predicting relapse in systemic vasculitis.  Q J Med. 1995;  88 127-133
• 11 Manganelli P, Fietta P, Carotti M. et al . Respiratory system involvement in systemic vasculitides.  Clin Exp Rheumatol. 2006;  24 S48-59
• 12 Lee D M, Schur P H. Clinical utility of the anti-CCP assay in patients with rheumatic diseases.  Ann Rheum Dis. 2003;  62 870-874
• 13 Parambil J G, Myers J L, Lindell R M, Matteson E L. et al . Interstitial lung disease in primary Sjögren syndrome.  Chest. 2006;  130 1439-1495
• 14 Prakash U B. Respiratory complications in mixed connective tissue disease.  Clin Chest Med. 1998;  19 733-746
• 15 Reuter M, Schnabel A, Wesner F. et al . Pulmonary Wegener’s granulomatosis: correlation between high-resolution CT findings and clinical scoring of disease activity.  Chest. 1998;  114 500-506